You will move to an external webpage. Are you sure?

Nobelpharma

News & Press Release

  • 2011-05-12 Announcements

Nobelpharma President & CEO Jin Shiomura, a director of SAMURAI Biotech Association, was appointed to be a constituent member for Introduction of the Regulatorial Strategy Consultation services for Pharmaceuticals and Medical Devices.

  1. 前の記事へ
  2. 一覧へ戻る（英語）
  3. 次の記事へ
PAGE TOP
  1. HOME
  2. News & Press Release
  3. Nobelpharma President & CEO Jin Shiomura, a director of SAMURAI Biotech Association, was appointed to be a constituent member for Introduction of the Regulatorial Strategy Consultation services for Pharmaceuticals and Medical Devices.